Impact of incorporating an algorithm that utilizes sentinel lymph node mapping during minimally invasive procedures on the detection of stage IIIC endometrial cancer

被引:55
作者
Leitao, M. M., Jr. [1 ,5 ]
Khoury-Collado, F. [1 ]
Gardner, G. [1 ,5 ]
Sonoda, Y. [1 ,5 ]
Brown, C. L. [1 ,5 ]
Alektiar, K. M. [2 ,5 ]
Hensley, M. L. [3 ,5 ]
Soslow, R. A. [4 ,5 ]
Barakat, R. R. [1 ,5 ]
Abu-Rustum, N. R. [1 ,5 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Gynecol Serv, Dept Surg, New York, NY 10065 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10065 USA
[3] Mem Sloan Kettering Canc Ctr, Gynecol Med Oncol Serv, Dept Med, New York, NY 10065 USA
[4] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA
[5] Weill Cornell Med Coll, New York, NY USA
关键词
Sentinel lymph node; SLN mapping; Endometrial cancer; GYNECOLOGIC-ONCOLOGY-GROUP; SURVIVAL; MANAGEMENT; CARCINOMA; TRIAL;
D O I
10.1016/j.ygyno.2013.01.002
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective. To determine whether the frequency of cases diagnosed with stage IIIC endometrial cancer is affected by the incorporation of a modified surgical lymph node assessment. Methods. Since 2008, we have increasingly utilized a modified nodal assessment using an algorithm that incorporates SLN mapping. For this analysis, we identified all cases of newly diagnosed endometrial cancers undergoing a minimally invasive staging procedure not requiring conversion to laparotomy from 1/1/08 to 12/31/10. Procedures were categorized as standard, modified, and hysterectomy only. Differences were based on time period: 2008 (Y1), 2009 (Y2), and 2010 (Y3). Appropriate statistical tests were used. Results. We identified a total of 507 cases. The distribution of cases was 143 (Y1), 190 (Y2), and 174 (Y3). Tumor grade (P=0.05) and high-risk histologies (P=0.8) did not differ during the 3 time periods. A standard staging procedure was performed in the following cases: Y1 (93/143; 65%), Y2 (66/166; 35%), and Y3 (40/164; 23%) (P<0.001). Median operative times were as follows: Y1 (218 min), Y2 (198 min), and Y3 (176.5 min) (P<0.001). The median numbers of total lymph nodes removed among cases with at least 1 node retrieved were: Y1 (20); Y2 (10); Y3 (7) (P<0.001). Cases diagnosed as stage IIIC were as follows: Y1 (10/143; 7%), Y2 (15/166; 7.9%), and Y3 (13/164; 7.5%) (P=1.0). Conclusions. The incorporation of a modified staging approach utilizing the SLN mapping algorithm reduces the need for standard lymphadenectomy and does not appear to adversely affect the rate of stage IIIC detection. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:38 / 41
页数:4
相关论文
共 50 条
  • [41] Sentinel lymph node mapping in endometrial cancer: a systematic review and meta-analysis
    Lin, Hefeng
    Ding, Zheyuan
    Kota, Vishnu Goutham
    Zhang, Xiaoming
    Zhou, Jianwei
    [J]. ONCOTARGET, 2017, 8 (28) : 46601 - 46610
  • [42] Added prognostic value of sentinel lymph node mapping in endometrial cancer to molecular subgroups
    Siegenthaler, Franziska
    Imboden, Sara
    Buechi, Carol
    Christe, Lucine
    Solass, Wiebke
    Saner, Flurina
    Rauh, Claudia
    Hofer, Seline
    Schlatter, Bettina
    Wampfler, Julian
    Mohr, Stefan
    Papadia, Andrea
    Anokhina, Maria
    Goering, Wolfgang
    Rau, Tilman T.
    Mueller, Michael D.
    [J]. GYNECOLOGIC ONCOLOGY, 2025, 193 : 12 - 19
  • [43] The impact of different doses of indocyanine green on the sentinel lymph-node mapping in early stage endometrial cancer
    Papadia, Andrea
    Buda, Alessandro
    Gasparri, Maria Luisa
    Di Martino, Giampaolo
    Bussi, Beatrice
    Verri, Debora
    Mueller, Michael D.
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2018, 144 (11) : 2187 - 2191
  • [44] Laparoscopic treatment of early-stage endometrial cancer: benefits of sentinel lymph node mapping and impact on lower extremity lymphedema
    Casarin, Jvan
    Schivardi, Gabriella
    Artuso, Valeria
    Giudici, Anna
    Meschini, Tommaso
    De Vitis, Luigi
    Granato, Vincenzo
    Lembo, Antonio
    Cromi, Antonella
    Mariani, Andrea
    Bogani, Giorgio
    Multinu, Francesco
    Ghezzi, Fabio
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024,
  • [45] Sentinel Lymph Node Mapping in Early Stage Endometrial Cancer Patients in Low-Resource Settings
    Negm, Mahmoud Abubakr
    Refaie, Ashraf Nasr
    El-Sayed, Magdi Ragab
    Azeez, Hesham R. Abdel
    Gad, Abdalla Hassan
    Wasfy, Mohamed Ahmed
    Nasr, Ahmed Abobakr
    [J]. CURRENT WOMENS HEALTH REVIEWS, 2021, 17 (03) : 251 - 259
  • [46] Retrospective review of sentinel lymph node mapping in endometrial cancer using indocyanine green and near infra-red fluorescence imaging during minimally invasive surgery
    Chaowawanit, W.
    Campbell, V
    Wilson, E.
    Chetty, N.
    Perrin, L.
    Jagasia, N.
    Barry, S.
    [J]. EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2021, 42 (04) : 694 - 702
  • [47] Sentinel lymph node detection in patients with endometrial cancer
    Niikura, H
    Okamura, C
    Utsunomiya, H
    Yoshinaga, K
    Akahira, J
    Ito, K
    Yaegashi, N
    [J]. GYNECOLOGIC ONCOLOGY, 2004, 92 (02) : 669 - 674
  • [48] The Assessment of Sentinel Lymph Node Mapping Methods in Endometrial Cancer
    Szatkowski, Wiktor
    Pniewska, Karolina
    Janeczek, Maja
    Rys, Janusz
    Banas, Tomasz
    Muzykiewicz, Konrad
    Iwanska, Ewa
    Jakubowicz, Jerzy
    Karolewski, Kazimierz
    Szadurska, Agnieszka
    Blecharz, Pawel
    [J]. JOURNAL OF CLINICAL MEDICINE, 2025, 14 (03)
  • [49] Can mismatch repair status be added to sentinel lymph node mapping algorithm in endometrioid endometrial cancer?
    Diniz, Thiago Pereira
    Menezes, Jacqueline Nunes
    Goncalves, Bruna Tirapelli
    Faloppa, Carlos Chaves
    Mantoan, Henrique
    Kumagai, Lillian Yuri
    Badiglian-Filho, Levon
    Bovolim, Graziele
    Guimaraes, Andrea Paiva Gadelha
    De Brot, Louise
    Baiocchi, Glauco
    [J]. GYNECOLOGIC ONCOLOGY, 2023, 169 : 131 - 136
  • [50] The Increasing Credibility of Sentinel Lymph Node Mapping in Endometrial Cancer
    Abu-Rustum, Nadeem R.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2013, 20 (02) : 353 - 354